Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
25.83
-0.15 (-0.58%)
At close: Jul 2, 2026, 4:00 PM EDT
25.80
-0.03 (-0.12%)
After-hours: Jul 2, 2026, 7:38 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $4.1 billion as of July 2, 2026. Its market cap has increased by 101.42% in one year.
Market Cap
4.10B
Enterprise Value
3.09B
1-Year Change
101.42%
Ranking
Category
Stock Price
$25.83
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $4.10B, an increase of 117.23%. That is a compound annual growth rate of 9.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 4.10B | 69.30% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 4.45B |
| Viking Therapeutics | 4.35B |
| Tango Therapeutics | 4.26B |
| Edgewise Therapeutics | 4.26B |
| NewAmsterdam Pharma Company | 4.07B |
| Relay Therapeutics | 4.06B |
| Telix Pharmaceuticals | 3.97B |
| Catalyst Pharmaceuticals | 3.85B |